rs146450828
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6
The NM_213655.5(WNK1):c.1834G>A(p.Gly612Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,613,868 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G612D) has been classified as Uncertain significance.
Frequency
Consequence
NM_213655.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WNK1 | NM_213655.5 | c.1834G>A | p.Gly612Ser | missense_variant | 7/28 | ENST00000340908.9 | |
WNK1 | NM_018979.4 | c.1834G>A | p.Gly612Ser | missense_variant | 7/28 | ENST00000315939.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WNK1 | ENST00000340908.9 | c.1834G>A | p.Gly612Ser | missense_variant | 7/28 | 5 | NM_213655.5 | A2 | |
WNK1 | ENST00000315939.11 | c.1834G>A | p.Gly612Ser | missense_variant | 7/28 | 1 | NM_018979.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 151878Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000243 AC: 61AN: 250976Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135614
GnomAD4 exome AF: 0.000140 AC: 205AN: 1461876Hom.: 1 Cov.: 33 AF XY: 0.000129 AC XY: 94AN XY: 727242
GnomAD4 genome AF: 0.000132 AC: 20AN: 151992Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74304
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 13, 2021 | The WNK1 c.1834G>A; p.Gly612Ser variant (rs146450828), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 310740). This variant is found in the Latino population with an allele frequency of 0.079% (28 /35420 alleles) in the Genome Aggregation Database. The glycine at codon 612 is moderately conserved, and computational analyses predict that this variant is neutral (REVEL: 0.086). Due to limited information, the clinical significance of the p.Gly612Ser variant is uncertain at this time. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 31, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2022 | The c.1834G>A (p.G612S) alteration is located in exon 7 (coding exon 7) of the WNK1 gene. This alteration results from a G to A substitution at nucleotide position 1834, causing the glycine (G) at amino acid position 612 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Pseudohypoaldosteronism type 2C Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at